Predisposing genetic risk factors for Barrett*s Esophagus

Not yet recruiting

• Conditions: Barretts esophagus; cell abnormality in the lower esophagus; 10017934

• Registration Number: NL-OMON39802
• Lead Sponsor: Erasmus MC, Universitair Medisch Centrum Rotterdam

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 29 April 2024

Recruitment & Eligibility

• Status: Pending
• Sex: Not specified
• Target Recruitment: 600

Inclusion Criteria

Patients with Barrett*s disease

Exclusion Criteria

Patients without histological confirmation of BE

Study & Design

• Study Type: Observational invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Primary endpoint: regions on human genome that are associated with BE.</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>Secondary endpoints are: BE length, complication of BE (dysplasia, ulcer,<br /><br>stricture or EAC), presence of esophagitis and hiatal hernia, patients* BMI,<br /><br>medication and cardiac history</p><br>